Search

everythinglearnresearchcommunity

for

Search:↓

Gamma rays did not change hair follicle density but increased white and hypopigmented hairs in mice.

The conclusion is that modifying scalp lifting surgery by cutting one occipital artery and making other changes reduces complications and improves outcomes for patients with severe hair loss.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

The conclusion is that three signs can help diagnose hair loss after it happens, potentially avoiding more invasive tests.

Ahmad's NPRT system accurately documents and predicts male pattern baldness.

A man's sudden hair loss and color change to white was diagnosed as alopecia areata and it improved on its own after six months.

Minoxidil can increase hair density, speed up regrowth in transplanted hair, and slow down further hair loss, especially beneficial for women, young men with thinning hair, and those wanting to reconstruct the back of the scalp.

Higher cannabis exposure may lead to increased hair loss.

Higher cannabis use may be linked to more severe hair loss.

Understanding different types of hair loss helps in accurate diagnosis and treatment.

Chemical hair straighteners can severely damage hair and scalp with repeated use.

Herbal extracts like Ficus religiosa may help with hair growth and skin rejuvenation.

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

SMP creates illusion of full hair, addressing various issues and bringing happiness to those with thinning hair.

Fat-derived stem cells show promise for skin repair and reducing aging signs but need more research for consistent results.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

The study concluded that a special imaging technique showed women with hair loss have slower hair growth and a faulty hair replacement cycle.

Facial aging is caused by natural processes and external factors, and can be managed with preventative measures and a variety of treatments tailored to individual needs.

Hair thickness matters more than density for baldness in Japanese men over 25.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The conclusion is that accurate diagnosis of different types of hair loss requires careful examination of tissue samples and understanding of clinical symptoms.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

mTORC1 signaling needed for quick hair follicle recovery after radiation damage.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.